Jonathan Burns - Faculty Biosketch

Jonathan Burns, PharmD

Adjunct Assistant Professor of Medicine (Infectious Diseases)

Department: Medicine

Contact information

Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center
3900 Woodland Ave
Philadelphia, PA 19104

Education:
Bachelor's (Bachelor of Science in Pharmaceutical and Healthcare Studies)
University of the Sciences, Philadelphia College of Pharmacy, 2015.
PharmD (Doctor of Pharmacy )
University of the Sciences, Philadelphia College of Pharmacy , 2017.

Post-Graduate Training
PGY-1 Pharmacy Practice Resident, Hospital of the University of Pennsylvania, Philadelphia, PA, 2017-2018.
PGY-2 Infectious Diseases Pharmacy Resident, Hospital of the University of Pennsylvania, Philadelphia, PA, 2018-2019.

Certifications
Pennsylvania Pharmacist License Number: RP451629 , 2017.
Pennsylvania Authorization to Administer Injectables License Number: RPI011544 , 2017.
Pittsburgh Screening, Brief Intervention, and Referral to Treatment Training Certified through the Pennsylvania Pharmacists Association, 2018.
New Jersey Pharmacist License Number: 28RI04023300 , 2019.
Human Subjects Protection and Good Clinical Practices Training Certified through CITI Program , 2020.
Basic Life Support Certified through the American Heart Association, 2020.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG, Stadtmauer EA, Loren AW: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. American Journal of Hematology 95(7): 792-798, July 2020.

Burns J, Mersinger K, Saw S, Morgan S, Athans V, Pegues D, Degnan K, Dutcher L, Binkley S, Hamilton K. : Characterization of antibiotic superutilizers in the inpatient setting. Infectious Disease Week, Washington, DC 6(Supplement 2): S356, October 2019 Notes: Poster Presentation.

Kim G, Burns J, Freyer C, Hamilton K, Schuster M, Frey N, Hexner E, Mangan J, Martin ME, McCurdy S, Perl A, Porter D, Luger S, Loren A: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. Blood 2018 132 (Suppl 1): 5512. Abstract. American Society of Hematology Annual Meeting and Exposition, San Diego, CA 132(Supplement 1): 5512, December 2018 Notes: Poster Presentation.

Burns J, Ziolek T, Tietze K: Readability and length of high risk informed consent forms. Journal of Undergraduate Research and Scholarly Excellence JUR Press, IX(1): 5, Annual Journal 2018.